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Pbx1 is a TALE-class homeodomain protein that functions in part as a cofactor for Hox class homeodomain proteins. Previous analysis of
the in vivo functions of Pbx1 by targeted mutagenesis in mice has revealed roles for this gene in skeletal patterning and development and in
the organogenesis of multiple systems. Both RNA expression and protein localization studies have suggested a possible role for Pbx1 in
pharyngeal region development. As several Hox mutants have distinct phenotypes in this region, we investigated the potential requirement
for Pbx1 in the development of the pharyngeal arches and pouches and their organ derivatives. Pbx1 homozygous mutants exhibited delayed
or absent formation of the caudal pharyngeal pouches, and disorganized patterning of the third pharyngeal pouch. Formation of the third
pouch-derived thymus/parathyroid primordia was also affected, with absent or hypoplastic primordia, delayed expression of organ-specific
differentiation markers, and reduced proliferation of thymic epithelium. The fourth pouch and the fourth pouch-derived ultimobranchial
bodies were usually absent. These phenotypes are similar to those previously reported in Hoxa3/ single mutants and Hoxa1/;Hoxb1/
or Hoxa3+/;Hoxb3/;Hoxd3/ compound mutants, suggesting that Pbx1 acts together with multiple Hox proteins in the development of
the caudal pharyngeal region. However, some aspects of the Pbx1 mutant phenotype included specific defects that were less severe than those
found in known Hox mutant mice, suggesting that some functions of Hox proteins in this region are Pbx1-independent.
D 2004 Elsevier Inc. All rights reserved.
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In mammalian embryogenesis, the biological functions
of the homeobox gene Pbx1, initially identified at the site of
a chromosomal translocation in acute pediatric leukemias
(Kamps et al., 1990; Nourse et al., 1990), remain poorly
understood in comparison to its well-characterized role as a
DNA-binding partner with Hox proteins (Mann and
Affolter, 1998). Pbx1 is a three amino acid loop extension0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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1 These authors equally contributed to the work.(TALE) class homeodomain protein (Burglin, 1997) that can
also dimerize with other TALE homeodomain proteins, such
as Meis/Prep (Berthelsen et al., 1999). As a TALE
heterodimer, Pbx1 displays an ability to simultaneously
bind DNA with a subset of Hox proteins and can form
trimeric complexes on appropriate DNA sites (Ferretti et al.,
2000; Jacobs et al., 1999). Numerous studies have
demonstrated that Pbx1–Hox interactions result in enhanced
DNA binding affinities and specificities in vitro (Chan et al.,
1994, 1997; Chang et al., 1995, 1996; Knoepfler and
Kamps, 1995; Lu et al., 1995; Peers et al., 1995; Peltenburg
and Murre, 1996; Phelan et al., 1995; Shen et al., 1996; van
Dijk and Murre, 1994). These interactions are confined to a
subset of Hox and other homeodomain proteins that contain
characteristic tryptophan-bearing dimerization motifs.276 (2004) 301–312
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vivo support that Pbx and exd proteins (Peifer and
Wieschaus, 1990; Rauskolb et al., 1993) function in concert
with Hox proteins during development through response
elements containing their cognate DNA binding sites (Chan
et al., 1994; Maconochie et al., 1997; Popperl et al., 1995).
Thus, Pbx proteins appear to play diverse roles as
components of various protein complexes to orchestrate
transcriptional and developmental programs in multiple
tissues.
Our recent studies demonstrate a critical role for Pbx1 as
a developmental regulator, whose absence results in
embryonic lethality at around gestational days 15–16
(E15–16) with multiple tissue and organ system abnormal-
ities (Selleri et al., 2001). Specifically, we demonstrated that
Pbx1 is required for patterning and skeletal development
(Selleri et al., 2001), maintenance of definitive hematopoi-
esis in the fetal liver (DiMartino et al., 2001), pancreatic
development and function (Kim et al., 2002), and urogenital
and adrenal organ development (Schnabel et al., 2003a,b).
Because of the known interactions of Pbx and Hox
proteins, clues to additional roles of Pbx1 in development
may come from Hox gene mutants (Krumlauf, 1994). Pbx1
is expressed in the pharyngeal region during embryonic
development (Schnabel et al., 2001), and several single and
multiple Hox mutants have phenotypes in this region
(Chisaka and Capecchi, 1991; Manley and Capecchi,
1995, 1998; Rossel and Capecchi, 1999). The vertebrate
pharyngeal region is the source of the endoderm-derived
glandular organs, the thyroid, ultimobranchial bodies,
thymus, and parathyroids, which play a variety of essential
physiological roles. The pharyngeal organs all originate
from out-pocketings of the pharyngeal endoderm, either in
the form of pharyngeal pouches or the thyroid diverticulum,
and require interactions between the endoderm and sur-
rounding mesenchyme for their development (Grapin-
Botton and Melton, 2000). The pharyngeal pouches are
transient, bilateral out-pocketings of the pharyngeal endo-
derm that form in an anterior to posterior order beginning at
about E8.5. Each of the pouches contacts the surface
ectoderm about 1 day after formation, via ectodermal
invaginations called pharyngeal clefts. The pharyngeal
pouches are directly surrounded by pharyngeal arch
mesenchyme, which is primarily composed of neural crest
cells (NCCs), although there is also a mesodermal compo-
nent in the center of each arch (LeLievre and LeDouarin,
1975). Experimental and genetic evidence indicates that
both endoderm and NCC mesenchyme are directly involved
in the development of all of these pharyngeal organs
(Grapin-Botton and Melton, 2000; Manley and Blackburn,
2003).
The best-characterized Hox mutant with pharyngeal
region defects is Hoxa3. Hoxa3 mutants have normal initial
pharyngeal pouch formation, but have severe defects in
pharyngeal organ development, including athymia, apara-
thyroidism, and thyroid hypoplasia, in addition to a broadspectrum of neural, skeletal, and cardiovascular defects
(Chisaka and Capecchi, 1991; Kameda et al., 2002; Manley
and Capecchi, 1995). Mice carrying mutations in all of the
Hox3 paralogs (Hoxa3+/;Hoxb3/;Hoxd3/ ) have
ectopic thymus and parathyroids (Manley and Capecchi,
1998). Furthermore, mice mutant for both the Hoxa1 and
Hoxb1 genes have severe defects in both posterior pouch
formation and pharyngeal organ development (Rossel and
Capecchi, 1999). Taken together, these results indicate that
Hox genes play roles in both formation and patterning of the
posterior pharyngeal pouches and their organ derivatives. It
is currently unclear, however, which potential cofactors may
contribute to or modify the Hox program in these sites.
To address Pbx1 function in vertebrate pharyngeal pouch
formation, patterning, and organ development, mice homo-
zygous for a null allele of Pbx1 (Selleri et al., 2001) were
examined for pharyngeal region phenotypes. In the current
study, we show that Pbx1/ mutant embryos exhibited
phenotypes that are similar to or more severe than
abnormalities in pharyngeal development caused by single
or multiple Hox gene mutations, and suggest that Pbx1 acts
collaboratively with several different Hox proteins in the
development of the pharyngeal region. Furthermore, some
aspects of the Pbx1 mutant phenotype are not as severe as
reported Hox mutant pharyngeal phenotypes, suggesting
either that interactions with Pbx proteins are not required for
all Hox-dependent aspects of pharyngeal development, or
that other Pbx proteins are providing redundant function in
this region.Materials and methods
Generation and genotyping of Pbx1/ mice
Targeted disruption of Pbx1 and genotyping of embryos
by PCR and Southern hybridization were performed as
described (Selleri et al., 2001). Phenotypes were analyzed in
mice derived from either of two independently targeted lines
that were generated on a mixed 129/Sv-C57BL/6J genetic
background. Pbx1 heterozygous mice were born at the
expected Mendelian ratios and did not display any
anatomical abnormalities, except reduced weight (Kim et
al., 2002; Selleri et al., 2001).
Histology and immunohistochemistry
For histological analysis, embryos were fixed in formalin
and embedded in paraffin for sectioning using standard
procedures. Five-micron sections were stained with hema-
toxylin and eosin, mounted in DPX and photographed using
a Magnafire digital camera (Optronix). Immunohistochem-
istry was performed on dewaxed paraffin sections following
microwave antigen retrieval (Schnabel et al., 2001). The
primary antibody used to detect Pbx1 protein was a mouse
Pbx1b-specific monoclonal antibody (aPbx1b; (Jacobs et
N.R. Manley et al. / Developmental Biology 276 (2004) 301–312 303al., 1999). Specificity of the antibody was previously
demonstrated by lack of signal on Pbx1 homozygous null
embryos (Schnabel et al., 2003a; Selleri et al., 2001).
Analysis of BrdU incorporation
Pregnant mice were injected intravenously with BrdU at
a dose of 50 Ag/g of body weight 1 h before sacrifice.
Embryos were fixed and embedded in paraffin as above to
obtain transverse sections. BrdU was detected by immuno-
histochemistry as described (Nowakowski et al., 1989;
Selleri et al., 2001) and sections were counterstained lightly
with hematoxylin and eosin. Monoclonal anti-BrdU was
purchased from Roche. All BrdU-positive (dark brown) and
negative (blue) nuclei were counted over various sections.
At least five different sections containing thymic primordia
were analyzed for each wild-type and Pbx1/ littermate
embryo (2 wild-type and 4 Pbx1/ at E12.5; 2 wild-type
and 2 Pbx1/ at E11.5 and 1 wild-type and 1 Pbx1/ at
E13.5). Sections were digitized using an Eclipse E600
microscope (Nikon). For each section, outlines of the
thymic lobes were traced manually, corresponding areas
were computed and positive and negative cells counted
digitally (Stereo Investigator Software Package, Version
5.05.4, Microbrightfield). Approximately 200 total cells
were counted per each section, and right and left thymic
lobes were analyzed independently.
Whole mount in situ hybridization
Whole mount in situ hybridization was performed as
described (Carpenter et al., 1993; Manley and Capecchi,
1995), using Pbx1/ and littermate control embryos. The
Hoxa3, Pax1 (Manley and Capecchi, 1995), Gcm2, Foxn1
(Gordon et al., 2001), AP2 (Rossel and Capecchi, 1999),
and Tbx1 (Jerome and Papaioannou, 2001) in situ hybrid-
ization probes have been previously described.Table 1
Summary of Pbx1/ pharyngeal pouch-derived organ phenotypes
Stage Thymus phenotype Para
E11.5 3/3 bilateral hypoplastica,b 3/3
E12.5 1/6 bilateral hypoplastic 2/6
2/6 bilateral hypoplastic, ectopic 2/6
3/6 unilateral, ectopic 2/6
E13.5 2/5 bilateral hypoplastic, ectopic 1/5
1/5 unilateral 4/5
2/5 absent
E15.5 2/3 bilateral hypoplastic, ectopic 2/3
1/3 absent 1/3
a E11.5 embryos were scored for the third pouch common thymus/parathyroid pr
smaller than littermate controls.
b Of four other Pbx1/ embryos assayed for Foxn1 expression at this stage,
expression on one side with the other side lost in processing. Foxn1-positive lob
c Of three other Pbx1/ embryos assayed for Gcm2 expression at this stage, tw
d Embryos listed as not scorable had damaged or missing sections that precluded
e Not Detected—since ultimobranchial bodies are usually fused to the thyroid at th
organs, which were never seen in these mutants.Results
Pbx1/ mutants have defects in pharyngeal organ
formation
As an initial analysis of pharyngeal region development
in Pbx1/ embryos, we performed a histological assess-
ment of pharyngeal pouch derivatives in E11.5–E15.5
Pbx1/ and littermate control embryos. In wild-type
embryos, the second pouch degenerates by E12 without
forming any further structures. Each third pouch gives rise
to a single organ primordium that forms at about E11 and
then separates into one thymic lobe and one parathyroid
gland by E13.5 (Manley and Blackburn, 2003). The fourth
pouch derivatives are the ultimobranchial bodies, which
form at E11.5 and fuse with the thyroid diverticulum
beginning at E13.5 to contribute calcitonin-producing C
cells to the thyroid gland. A summary of the third and fourth
pouch-derived organ phenotypes in the Pbx1 mutants is
shown in Table 1.
At E11.5 in control embryos, the second pouch was still
present but beginning to degenerate (data not shown), while
the third and fourth pouch-derived organ primordia had
begun to form, but were still attached to the pharynx (Figs.
1A, D). In all three of the Pbx1/ mutants examined
histologically at E11.5, third pouch derived organ primordia
were present on both sides, but showed variable hypoplasia
compared to controls (Figs. 1B, C). In one embryo, one of
the third pouch primordia was also fused to the second
pouch (data not shown). Other than this one case, the second
pouches appeared normal in all mutant embryos examined
(data not shown). The most severe defects were seen in the
fourth pouch, where all three embryos analyzed had missing
or small fourth pouches, with no evidence of ultimobran-
chial body formation (Fig. 1E).
In control embryos at E12.5, the third and fourth pouch-
derived organ derivatives had separated from the pharynxthyroid phenotype Ultimobranchial body phenotype
bilateral hypoplastica,c 3/3 absent
bilateral 2/6 unilateral hypoplastic
unilateral 3/6 absent





imordia. Size of the primordia when present varied, but was always clearly
one had no detectable expression, two had unilateral expression, one had
es had only very small expression domains (see Fig. 6).
o had bilateral expression and one had unilateral expression (see Fig. 6).
definitive evaluation of the phenotype.
is stage, the only phenotype detectable at this stage is persistent or unfused
Fig. 1. Pharyngeal organ phenotypes in Pbx1/ embryos at E11.5–E12.5. Transverse H&E-stained sections of E11.5 (A–E) and E12.5 (F–J) wild-type (A, D,
F, I) or Pbx1/ (B, C, E, G, H, J) embryos. Organ primordia in A–D and G–J are outlined in black. (A) The common thymus/parathyroid primordium in a
wild-type embryo, still attached to the pharynx at this stage. (B) An example of a mild Pbx1/ phenotype, with a well-formed but hypoplastic primordium.
The other side of this embryo had no primordium formation. (C) Example of a severely hypoplastic third pouch (p3) primordium from a second littermate
mutant embryo. (D) Ultimobranchial body (ub) in a wild-type embryo. The pharynx (ph) at this stage has not yet developed a separate trachea and esophagus.
(E) Section of a mutant embryo in the general position where a ub should have formed showed no primordium formation. (F) Wild-type embryo showing
thymic lobes (th), ubs, and ventral thyroid (ty). Note that the esophagus (es) and trachea (tr) are well developed and are separated at this level. (G) Ectopic but
normally sized thymic lobe in a Pbx1/ littermate. The thymus is located above the esophageal–tracheal split. No thymus or parathyroid was present on the
other side of this embryo. (H) A second Pbx1/ littermate with a thyroid only on one side and a possible ub on the other. Note the abnormal morphology of
the esophagus. (I) A more anterior section from the same embryo as in (F), showing the parathyroid and anterior tip of the thymus. (J) Ectopic parathyroid and
thymus from the same embryo as in (H). The apparent difference in size is due to a slight difference in the plane of section. This embryo had only one thymus
and parathyroid. Scale bars: (A–E, I, J) 30 Am; (F–H) 60 Am.
N.R. Manley et al. / Developmental Biology 276 (2004) 301–312304and begun migrating ventrally and caudally. The thymic
lobes in particular were significantly larger (Fig. 1F), and
contained developing T cells (thymocytes) as identified by
histological analysis (not shown). Ultimobranchial bodies
were associated with the anterior and dorsal aspects of the
thyroid lobes, but had not yet begun to fuse with the thyroid
(Fig. 1F). Of the six Pbx1/ mutant embryos examined by
histology at this stage, three had only a single ectopic
thymus/parathyroid rudiment (Fig. 1G). In the other three
mutants, two thymus/parathyroid rudiments were present,
all of which were severely hypoplastic, and in two embryos
were both ectopic, consistent with defective organ migra-tion. Although the parathyroids at this stage are normally
closely associated with the thymic lobes, they were readily
identified in all control embryos assayed (Fig. 1I). Para-
thyroid development was identified in all four scorable
mutants at this stage (Fig. 1J). Consistent with the abnormal
fourth pouch development at E11.5, only two of five E12.5
embryos scored for this phenotype had a single, very small
fourth pouch derivative (Fig. 1H).
Phenotypes observed at later stages were similar to those
seen at E12.5. At E13.5 in control embryos, the ultimo-
branchial bodies had begun to fuse with the thyroid lobes,
and the parathryoids were located lateral to the thyroid
Fig. 3. Reduced proliferation in Pbx1/ embryos at E11.5. Proliferation
was assayed by BrdU incorporation (brown cells). Cell counts were
performed on transverse paraffin sections counterstained with hematoxylin.
(A) Pbx1+/ thymic lobe section with 33% BrdU-positive cells. (B) Section
of a thymic lobe in a Pbx1/– littermate with 19% BrdU incorporation. (C)
Very small thymic lobe from another Pbx1/ embryo with few or no
BrdU-positive cells. (D) Scatterplots of average BrdU-positive cell counts
per thymic lobe, with means indicated. Average values in the two mutant
columns (*) were calculated excluding the thymic lobes that were absent or
had no BrdU-positive cells. Scale bar: 100 Am.
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E12.5, had descended to the posterior aspect of the thyroid,
and were located more medially (Fig. 2B). In contrast, two
out of five Pbx1 mutants had no pharyngeal pouch-derived
organs (Fig. 2D), and one had only a single, relatively
normal sized but ectopically located thymic lobe (Fig. 2C).
The remaining two did have bilateral thymic rudiments,
although they were extremely hypoplastic (data not shown).
No evidence of ultimobranchial bodies was found at this
stage. Furthermore, the thyroid glands in at least three
mutants were very small and poorly formed (Fig. 2C). It is
not clear whether this thyroid phenotype was a primary
defect, or was secondary to the absence of ultimobranchial
bodies, which normally begin to fuse with the thyroid at this
stage. At the latest stage observed, E15.5, one of three
mutant embryos showed no pouch-derived organs, while the
remaining two had bilateral, hypoplastic, and ectopic thymic
lobes and contained bilateral and ectopic parathyroids
(Table 1 and data not shown).
Proliferation is reduced in the early thymic/parathyroid
rudiment
Both Pbx1 (DiMartino et al., 2001; Kim et al., 2002;
Selleri et al., 2001) and Hox genes (Condie and Capecchi,
1993, 1994; Duboule, 1995; Goff and Tabin, 1997; Su et al.,
2001; Yueh et al., 1998) have been implicated in regulating
proliferation. To investigate whether the smaller thymicFig. 2. Pharyngeal organ phenotypes in Pbx1/ mice at E13.5. Transverse
H & E stained sections of one wild-type (A, B) and two different littermate
Pbx1/ (C, D) embryos. (A) Section showing the parathyroids (pt), and
the ultimobranchial bodies (ub) fusing to the dorsal anterior thyroid (ty).
Note the well-developed esophagus (es) and trachea (tr). (B) A more
posterior section of the same embryos in (A), showing the thymic lobes (th)
and the ventral thyroid. (C) Pbx1/ littermate with a single, ectopic
thymic lobe and thyroid on the opposite side. Note the abnormal pharyngeal
morphology and failure of esophageal differentiation (ph/es). This section is
in a slightly coronal plane, resulting in an abnormal appearance of the
trachea. (D) A second Pbx1/ littermate with a bilateral thyroid but no
parathyroids, thymic lobes, or ubs. Scale bars: 50 Am.rudiments were the result of reduced proliferation, we used
BrdU incorporation to measure proliferation in two mutant
and two littermate control embryos during early organo-
genesis at E11.5–12.5. Both control embryos taken at E11.5
had large bilateral third pouch-derived primordia, with 25–
30% BrdU-positive cells (Figs. 3A, D). As was expected
from the histological analysis, in both of the mutants
examined only one third pouch-derived lobe was present.
In one case, an epithelial structure that was likely a remnant
of the third pouch was present on the other side, but
contained no BrdU-positive cells (Fig. 3C), and in the other
mutant embryo, no signs of organ formation were present on
one side. In the one lobe that was present in each mutant
embryo, proliferation was consistently decreased in the
thymic rudiment by approximately 50% (Figs. 3B, D). As
this stage is prior to significant lymphocyte progenitor
infiltration of the rudiment, this decrease in proliferation is
most likely to be a primary defect in the thymic epithelium
or mesenchyme.
At E12.5, both thymic lobes in the control embryo had
about 40% BrdU-positive cells (Fig. 3D). This increase in
proliferating cells relative to E11.5 was likely due in part to
the presence of proliferating hematopoietic-derived lym-
phocyte progenitor cells (LPCs), which have begun to
infiltrate the thymus at this stage. LPCs were also present in
the mutant thymic lobes, which could have masked any
change in epithelial cell proliferation. However, two of the
three thymic lobes counted from Pbx1/ embryos had
Fig. 4. Pbx1 nuclear localization in the third and fourth pharyngeal pouch
region. Coronal sections stained by immunohistochemistry for Pbx1 in
wild-type embryos at E9.5 (A, B) and E10.5 (C, D). B and D show higher
magnification pictures of A and C. Nuclear localized Pbx1 is most
prominent in the mesenchyme, endoderm, and ectoderm of the fourth arch
at E9.5. At E10.5, nuclear Pbx1 is most clearly seen in the pouch
endoderm and surface ectoderm, as well as in subpopulations of
mesenchyme. a3, third arch; a4, fourth arch; p3, third pouch; p4, fourth
pouch. Scale bars: (A, C) 85 Am; (B, D) 170 Am.
Fig. 5. Hoxa3 and AP2 expression are normal in Pbx1/ embryos. Whole
mount in situ hybridization for Hoxa3 (A, B) at E10.5 and AP2 (C, D) at E9
on wild-type and littermate Pbx1/ embryos. ov, otic vesicle.
N.R. Manley et al. / Developmental Biology 276 (2004) 301–312306proliferation levels that were reduced to 60% of wild type
levels (Fig. 3D), indicating that either the epithelial cells or
LPCs or both had reduced proliferation at this stage.
Nuclear localized Pbx1 in the pharyngeal endoderm and
mesenchyme
We previously reported that nuclear-localized Pbx1
protein is present within the anterior pharyngeal region at
E9.5–10.5 (Schnabel et al., 2001; Selleri et al., 2001), and in
the mesenchyme of the second pharyngeal arch at E11.5,
while the mesenchyme of the mandibular and maxillary
branches of the first arch show much lower levels of Pbx1
expression (Selleri et al., 2001). However, these analyses
were focused on the first and second pharyngeal arches,
rather than the more caudal arches and pouches, which are
the origins of the pharyngeal organs that were affected in the
Pbx1 mutants. Furthermore, the phenotype found in the
current study suggested that development of the caudal
pouches was defective in Pbx1/ embryos. Therefore, we
re-analyzed the localization of Pbx1 protein in wild type
E9.5 and E10.5 embryos, focusing on the caudal pharyngeal
region.
Nuclear Pbx1 protein was present in the surface
ectoderm, pharyngeal pouch endoderm, and in subsets ofarch mesenchyme at both E9.5 and E10.5 (Fig. 4). At E9.5,
nuclear localized protein levels were higher in the region
that will form the fourth arch and pouch in all cell types,
with graded expression anterior to this region (Figs. 4A, B).
By E10.5, the highest levels of nuclear localized Pbx1
protein were seen in the surface ectoderm and pouch
endoderm throughout the pharyngeal region (Figs. 4C, D).
At this stage, mesenchymal localization was more prom-
inent in subsets of mesenchyme in arches three and four.
Nuclear-localized Pbx1 was least prominent in the mesen-
chyme immediately surrounding the third pouch in the
region where the thymus/parathyroid primordia form (Fig.
3). This localization combined with the phenotypes
observed suggests that Pbx1 may be acting in multiple cell
types in the region. In particular, the more extensive and
earlier presence of nuclear-localized Pbx1 protein in the
region of the developing fourth pouch correlates with the
loss of fourth pouch formation. In contrast, pharyngeal
endoderm expression may be more important for the third
pouch phenotypes.
Marker gene analysis indicates defects in pouch formation
and patterning
Our histological analysis indicated that the Pbx1/
embryos had defects in the patterning and/or formation of
the pharyngeal pouches. We used marker gene analysis to
further investigate the possible changes in genetic regulatory
N.R. Manley et al. / Developmental Biology 276 (2004) 301–312 307networks underlying these defects. As expected, Hoxa3
expression was not changed at E9.5 or E10.5 (Figs. 5A, B,
and data not shown), indicating that overall A–P patterning
of the pharyngeal region was normal and underscoring the
notion that Pbx works in parallel with Hox proteins. Neural
crest migration also appeared relatively normal, as assayed
by AP2 expression in E9.0 Pbx1/ embryos (Figs. 5C, D),
and consistent with normal Hoxa3 expression in NCC at
E9.5 (data not shown).
Pax1 encodes a transcription factor that is present in all
of the developing pharyngeal pouches, and serves as a
marker for pouch formation. Accordingly, Pax1 is
expressed in the pouches from their initial formation
through about E11.5 (Wallin et al., 1996). At E9.5 in
control embryos, the first and second pouches were well
formed, while the third pouch was just beginning to form
(Fig. 6A). By E10.5, all four pharyngeal pouches were
formed and expressed Pax1, with the third pouch showing
the highest expression (Fig. 6C). In the Pbx1/ embryos at
E9.5 (24–26 somites), the first and second pouches
appeared relatively normal (Fig. 6B). However, the third
pouch was completely absent, as assessed both by
morphology and by the absence of Pax1 expression. ByFig. 6. Gene expression analysis of third pouch markers at E9.5 and E10.5 in Pbx
(E–H), and Tbx1 (I–L) at E9.5–E10.5 on wild-type and littermate Pbx1/ embry
is expressed in the first (p1), second (p2), and third (p3) pouches. Note the positi
(arrowhead) and the otic vesicle (ov). (B) No Pax1 staining is seen in the posi
although first and second pouch staining appears normal. (C) By E10.5, the fourth
the Pbx1 mutant, although its morphology appears abnormal compared to the wil
At E9.75 and E10.5, Gcm2 expression is seen only in the presumptive parathyro
pouch has begun to form. However, Gcm2 is expressed diffusely through the
consistently reduced in intensity compared to controls, and is variable in its dom
shows staining in the first and second arch mesodermal core, the posterior half of
E9.5 Pbx1/ embryo, the only detectable change is loss of Tbx1 in the region w
third pouch is restricted to a specific anterior–dorsal domain, similar to the Gcm2
Pbx1 mutant is more diffuse and spread throughout the pouch. h, heart.E10.5, a domain of Pax1 expression appeared just caudal to
the second pouch, although it did not have a morphology
typical of the third pouch (Fig. 6D). These data suggested
that third pouch formation was both delayed and abnormal
in Pbx1/ embryos.
We used additional molecular markers to further examine
the patterning of the third pharyngeal pouches at the
molecular level. Gcm2 encodes a transcription factor
required for parathyroid organogenesis, and is initially
expressed in a highly restricted pattern corresponding to
the putative parathyroid domain of the third pouch as early
as E9.5 (Fig. 6E), and is subsequently maintained in the
parathyroids during and after organ formation (Gordon et
al., 2001). In E10.5 control embryos, Gcm2 was expressed
in a specific dorsal anterior domain of the third pouch (Fig.
6G). In the Pbx1 mutant embryos, Gcm2 was expressed in
the third pouch at E9.75–E10 (28–30 somites), but at a
lower level throughout the pouch compared to wild-type
(Fig. 6F). This lower level, diffuse expression persisted
through E10.5 in the mutants (Fig. 6H), in contrast to the
strong localized expression in controls.
Mutation of Tbx1, a candidate gene for DiGeorge
syndrome, results in complete deletion of the second, third,1/ embryos. Whole mount in situ hybridization for Pax1 (A–D), Gcm2
os. In all panels, anterior is to the right and dorsal is up. (A) At E9.5 Pax1
on of the third pouch relative to the most anterior somite staining for Pax1
tion where the third pouch should form (*) in an E9.5 Pbx1/ embryo,
pouch is also positive for Pax1. (D) The third pouch is present at E10.5 in
d-type control, but the fourth pouch is not present by Pax1 staining. (E, G)
id anterior–dorsal domain. (F) In the Pbx1/ embryo at E9.75, the third
majority of the pouch. (H) At E10.5, the Gcm2 expression domain is
ain within the pouch. (I) Expression of Tbx1 in a control embryo at E9.5
the otic vesicle, and the developing third pouch endoderm (p3). (J) In the
here the third pouch should form (*). (K) At E10.5, Tbx1 expression in the
domain shown in (G). (L) Tbx1 expression in the third pouch of an E10.5
Fig. 7. Expression of thymus and parathyroid-specific markers is reduced
and delayed in Pbx1/ embryos. Whole mount in situ hybridization for
Foxn1 and Gcm2 in E11.5–E12.5 control and Pbx1/ embryos. A–C and
F–G show the inside surfaces of E11.5 embryos hemisected in the sagittal
plane. D–E show ventral views of partially dissected E12.5 embryos. In all
panels, arrowheads indicate the common parathyroid-thymic primordia. (A)
The thymic primordium at E11.5 expresses high levels of Foxn1. (B) An
E11.5 Pbx1/ embryo with an extremely small domain of Foxn1
expression. (C) Higher magnification of the Foxn1 expression domain in
the embryo in (B). (D) Control embryo with bilateral, large thymic lobes
expressing Foxn1. (E) Pbx1/ littermate with bilateral hypoplastic Foxn1-
positive thymic lobes. (F) Gcm2 expression marks the parathyroid domain
in an E11.5 wild-type embryo. (G) The Gcm2 expression domain in a
Pbx1/ littermate is smaller than in the control. However, the reduction in
the Gcm2 expression domain is not as great as that seen in the Foxn1
domain at the same stage (shown in B and C).
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are both athymic and aparathyroid (Jerome and Papaioan-
nou, 2001). Tbx1 is expressed in the pharyngeal pouch
endoderm, peri-cardiac mesenchyme, and the mesodermal
core of the first and second pharyngeal arches at E9.5–10.5
(Fig. 6I; (Garg et al., 2001). Strikingly, at E10.5 Tbx1
expression within the third pouch endoderm closely
resembled the highly localized Gcm2 expression pattern in
the dorsal third pouch endoderm (Fig. 6K). Most of the
Tbx1 expression pattern was normal in Pbx1/ embryos.
However, Tbx1 expression in the third pharyngeal pouch
was downregulated in Pbx1/ mutants relative to controls
in both E9.5 mutant embryos examined (Fig. 6J). By E10.5,
the third pouch expression was consistently decreased in all
three mutants examined, and more diffusely localized within
the pouch (Fig. 6L) relative to the highly localized
expression pattern in control embryos (Fig. 6K). The
Gcm2 expression pattern showed a similar change in the
Pbx1 mutants at this stage (Fig. 6H), suggesting that both
Gcm2 and Tbx1 expression are similarly affected by the loss
of Pbx1.
The E10.5 marker expression results suggested that the
dorsal–ventral patterning of the third pouch was abnormal
in the Pbx1 mutants. However, the histological analysis
showed that organ primordia were formed at E11.5,
although they were very small. To determine whether these
small third pouch primordia were patterned into thymus and
parathyroid-specific domains, we used the Gcm2 and
Foxn1 organ-specific markers. By E11.5 in control
embryos, both Gcm2 and Foxn1 have well-defined
complementary expression domains in the developing
primordia, with Foxn1 expressed in the large, ventral
thymic domain (Fig. 7A) and Gcm2 expressed in a much
smaller, dorsal parathyroid domain (Fig. 7F) (Gordon et al.,
2001). In the Pbx1 mutants at this stage, Foxn1 expression
was absent either bilaterally (1/4) or on one side (2/4), and
when present Foxn1 expression was very low and in a
much smaller domain relative to controls (Figs. 7B, C, E).
In contrast, Gcm2 expression was present in 3 of 3 Pbx1
mutant embryos examined (Fig. 7G), and in one case was
absent on one side (not shown). The Gcm2 domains were
consistently smaller than in controls (Fig. 7G), but the
relative reduction of the Gcm2 domain was not nearly as
great as was seen with Foxn1. The Foxn1 and Gcm2
expression patterns suggest that the patterning of the
primordia is abnormal in the Pbx1 mutants. This result is
consistent with the earlier relative expansion of the Gcm2
expression pattern at E10.5, and suggests that the thymus-
specific domain is selectively reduced and/or delayed in its
development. Analysis of Foxn1 expression at E12.5
showed that Foxn1 is expressed at this stage in a more
distinct pattern in the Pbx1 mutants (Fig. 7E), although its
domain is still reduced in Pbx1 mutant embryos relative to
controls (Fig. 7D), consistent with the smaller primordia
seen in the histological analysis. These results were
consistent with thymic epithelial specification and prolifer-ation being delayed and possibly abnormal in the Pbx1
mutants.Discussion
We have presented evidence that Pbx1 homozygous
mutants have abnormal and delayed third and fourth
pharyngeal pouch formation and patterning, resulting in
defective or absent development of the pharyngeal pouch-
derived thymus, parathyroids, and ultimobranchial bodies.
After organ formation, proliferation of the thymic epithelium
is decreased by 50%, resulting in further defects in organ
development. These Pbx1/ organ phenotypes are similar
to phenotypes previously reported for Hox1 and Hox3 single
and multiple gene mutants and to Hoxa3+/Pax1/
compound mutants. There is also a variable effect on thyroid
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ultimobranchial bodies, consistent with the thyroid defect in
Hoxa3 mutants (Manley and Capecchi, 1995). Our results
are consistent with Pbx1 acting together with multiple Hox
proteins and in multiple cell types to regulate pharyngeal
development.
At E9.5, when the caudal pharyngeal pouches are
forming, Pbx1 nuclear localization was most prominent in
the region where the fourth pouch will form, in the
ectoderm, mesenchyme, and endoderm. This is consistent
with the most severe and consistent phenotype in this
region, the failure of fourth pouch formation. Pbx1 mutants
also displayed a delay in the formation of the third
pharyngeal pouch at E9.5 as assayed by Pax1 expression.
These results further suggest that the dependence of Pax1
expression on Hoxa3 (Manley and Capecchi, 1995; Su et
al., 2001) does not require Pbx1, since Pax1 is expressed in
Pbx1 mutants, although delayed. The third pouch did form
by E10.5; however, its patterning was abnormal as indicated
by broadening of the Tbx1 and Gcm2 expression patterns
from their normal, tightly defined dorsal domains. In
contrast, NCC migration and A–P patterning of the
pharyngeal region was normal, as demonstrated by marker
analysis. These phenotypes in the third pouch correspond to
a Pbx1 nuclear localization at E10.5 that is strongest in the
pharyngeal ectoderm and endoderm, with more diffuse
staining in the surrounding mesenchyme. Taken together,
these results suggest that the Pbx1 mutant phenotypes,
particularly in pouch formation and patterning, may be
endoderm-intrinsic.
The similarities in both the normal and mutant expression
patterns of Tbx1 and Gcm2 in the third pouch are striking.
We have previously shown that Gcm2 expression is down-
stream of Hoxa3 and Pax1 (Su and Manley, 2000), and the
current data further suggest that this regulation is at least in
part Pbx1-dependent. Our data also suggest that Tbx1 may
also be downstream of Pbx1 function. Sequence analysis of
the Tbx1 promoter did reveal a Pbx1 binding site,
suggesting that the regulation of Tbx1 by Pbx1 could be
direct (L. Jerome and J. Papaioannou, personal communi-
cation). These results raise the possibility that Tbx1 and
Gcm2 function in the same pathway downstream of Pbx1 in
caudal pharyngeal pouch development. Interestingly, both
Tbx1 and Gcm2 expression have also been shown to be
downstream of Shh signaling (Garg et al., 2001; Yamagishi
et al., 2003). Alternatively, the similar changes in Tbx1 and
Gcm2 expression detected in the Pbx1 mutants could be an
indirect effect of delayed and abnormal third pouch
formation.
The defects in pouch formation and patterning in the
Pbx1 mutants are also reflected in the subsequent defects in
pharyngeal organ formation. Consistent with the failure of
fourth pouch formation, ultimobranchial bodies did not
form. The third pouch-derived organogenesis phenotypes
were somewhat less severe, as at least one organ primor-
dium was present in all of the embryos we examined atE11.5–12.5, although when present were often very small.
At these stages in control embryos, the third pouch-derived
primordia are patterned into parathyroid- and thymus-
specific domains by the expression of Gcm2 and Foxn1
(Gordon et al., 2001). In Pbx1 mutants at E11.5, these small
primordia usually expressed detectable levels of Gcm2, and
in 50% of the mutant embryos examined also expressed
Foxn1, indicating that they were patterned into organ-
specific domains. Since Foxn1 expression is normally
initiated at E11.25 (Gordon et al., 2001), those mutant
embryos in which Foxn1 expression was absent at this stage
either represent cases of absent primordia or could reflect a
delay in organ development, consistent with the delayed
third pouch formation at E10.5. The small organ primordia
at these stages could also reflect an additional role for Pbx1
in the mesenchyme during organogenesis, as the surround-
ing mesenchyme has been shown to provide growth signals
for the developing primordium as early as E12.5 (reviewed
in (Manley and Blackburn, 2003). This would be consistent
with our previous work showing that Pbx1 is required for
mesenchymal condensation and patterning during axial and
appendicular skeletal development (Selleri et al., 2001).
These earlier defects in third pouch-derived organ
formation result in three detectable phenotypes at later
stages, and are associated with decreased proliferation in
the developing primordium. In some cases, the thymus and
parathyroids are absent, presumably due to failure of initial
or sustained proliferation, as organ primordia were present
in most cases at E11.5, but showed reduced or absent
BrdU incorporation. In embryos in which the thymus was
present, this reduced proliferation could account for the
observed organ hypoplasia. The observed reduction in the
thymic epithelial cells is similar to that previously reported
in Hoxa3+/;Pax1/ mutants (Su et al., 2001), suggest-
ing that a Hoxa3–Pbx1 interaction may be involved in
promoting early thymic epithelial cell proliferation. Of the
thymic lobes that were present at E12.5 and later, most
were ectopic. However, in contrast to the ectopia seen in
Hoxa3+/;Pax1/ mutants, the ectopic organs seen at
later stages in Pbx1 mutants were not due to delayed
release from the pharynx, but appeared to be the result of a
defect in the intrinsic ability of the organ primordia to
migrate within the embryo.
As many of the functions for Pbx1 may be mediated by
interactions with Hox proteins, comparison to Hox mutants
with pharyngeal region phenotypes could help to identify
potential partners for Pbx1. Hoxa1;Hoxb1 double mutants
have a loss of the second arch and pouch and second pouch-
derived structures, and abnormal formation of the third
pouch and deletion of thymus and parathyroids; a fourth
pouch phenotype was not reported (Rossel and Capecchi,
1999). Pbx1 mutants have a second pharyngeal arch, but it
displays morphologic transformation of skeletal structures
(Selleri et al., 2001) reminiscent of, but not identical to, the
morphologic anteriorization observed in Hoxa2 mutants
(Rijli et al., 1993). Our data show that Pbx1 mutants display
N.R. Manley et al. / Developmental Biology 276 (2004) 301–312310normal second pouch formation, but do have delayed and
abnormal third pouch development, with some deletion of
the thymus and parathyroids. Therefore, some phenotypes
are similar, but less penetrant or less severe than in the
Hoxa1;Hoxb1 double mutants or Hoxa2 single mutants.
Strikingly, Pbx1 mutants have defects in the same organs
that are affected in Hox3 single and multiple mutants.
Hoxa3 mutants have normal pouch formation and less
severe fourth pouch phenotypes (organ formation is normal,
but defects appear later in development) compared to the
Pbx1 mutants. In contrast, Hoxa3 mutants display more
severe 3rd pouch organ phenotypes (complete absence of
thymus and parathyroids) (Chisaka and Capecchi, 1991;
Manley and Capecchi, 1995). Interestingly, the Pbx1 mutant
phenotype most closely mimics the thymus and parathyroid
phenotype of Hoxa3;Hoxb3;Hoxd3 multiple mutants, which
have ectopic and hypoplastic 3rd pouch-derived organs,
although the embryonic origins of that phenotype are not
known (Manley and Capecchi, 1998). This Hox3 multiple
mutant phenotype was proposed to be due to a neural crest
mesenchymal defect, suggesting by comparison that the
organ ectopia and hypoplasia seen in the Pbx1 mutants
could be due at least in part to interactions between Pbx1
and the Hox3 paralogous proteins in the mesenchyme. Pbx1
and Hoxa3 do not show any genetic interactions in double
heterozygotes (NRM and LS, unpublished data), further
suggesting that the pharyngeal organ defects may involve
multiple Hox3 paralogous genes.
Overall, the comparison of the Pbx1 caudal pharyngeal
pouch phenotype with known Hox mutant phenotypes
reveals a diverse scenario. Some Pbx1 phenotypes are
strikingly similar to Hox phenotypes in this region, such as
the organ ectopia and the partially penetrant loss of thymus
and parathyroids, suggesting obvious partners for some
Pbx1 functions. At the same time, other phenotypes are
either more or less severe than Hox mutant phenotypes. The
defects in pouch formation, particularly the fourth pouch,
could be due to interactions between Pbx1 and multiple
Hox1 and Hox3 proteins expressed in this region. Another
interesting question is how some Pbx1 single mutant
phenotypes could be less severe than Hox phenotypes,
since this could indicate that some Hox functions in this
region might be Pbx1-independent. For example, the Hoxa3
single mutant phenotype in the third pouch-derived organs
is uniformly more severe than the Pbx1 phenotype in the
same region (Chisaka and Capecchi, 1991; Manley and
Capecchi, 1995). This result could also indicate that some
Hox gene functions in the pharyngeal region depend on
interactions with other Pbx proteins. The two main
candidates for providing redundant functions are Pbx2 and
Pbx3. Pbx2 is ubiquitously expressed during early develop-
ment, but Pbx2 single mutants have no detectable pheno-
type (Selleri et al., 2004). On the other hand, Pbx3-deficient
mice do not have apparent defects in the pharyngeal region,
but die in the early neonatal period from central respiratory
failure due to abnormal activity of inspiratory neurons in theventrolateral medulla (Rhee et al., in press). Analysis of
compound Pbx gene mouse mutants will therefore be
required to identify potential roles for other Pbx proteins
in pharyngeal region development. A more intriguing
possibility is that some Hox protein functions are com-
pletely Pbx-independent. A recent study generated a Hoxb8
mouse mutant that was predicted not to bind Pbx proteins
and yet resulted in unexpected dominant phenotypes
(Medina-Martinez and Ramirez-Solis, 2003). Although
much still remains to be understood about Hox–Pbx
interactions and functions in vivo, our results unequivocally
demonstrate that Pbx1 is required for caudal pharyngeal
pouch development. Furthermore, our study indicates that
mutation of Pbx1 causes abnormalities in the caudal
pharyngeal region that most closely mimic the phenotype
of Hox3 multiple mutants, consistent with a scenario where
Pbx1 and a subset of Hox proteins act in concert to affect
pharyngeal region development.Acknowledgments
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